Frank Li
Amgen (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Pancreatic function and diabetes, Biochemical Analysis and Sensing Techniques
Most-Cited Works
- → A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents(2012)136 cited
- → AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents(2011)94 cited
- → Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist(2012)89 cited
- → Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles(2013)81 cited
- → Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists(2014)24 cited
- → Discovery of the imidazole-derived GPR40 agonist AM-3189(2015)18 cited